Risk scoring in primary prevention of atherosclerotic cardiovascular disease: Strengths and limitations

Abstract

Get full access to this article

View all access options for this article.

References

Roth

Huffman

Moran

, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 2015; 132: 1667–1678.

Danchin

Almahmeed

Al-Rasadi

, et al. Management of low-density lipoprotein cholesterol levels: The International Cholesterol Management Practice Study (ICLPS). Eur J Prev Cardiol 2018; 25: 1087–1094.

Rossello

Dorresteijn

JAN

Janssen

, et al. Risk prediction tools in cardiovascular disease prevention. Eur J Prev Cardiol. 2019; 26: 1534–1544.

Townsend

Wilson

Bhatnagar

, et al. Cardiovascular disease in Europe: Epidemiological update 2016. Eur Heart J 2016; 37: 3232–3245.

De Bacquer

De Backer

. Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality. Int J Cardiol 2010; 143: 385–390.

Karjalainen

Adiels

Björck

, et al. An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk. The Northern Sweden MONICA Study 1999–2014. Eur J Prev Cardiol 2017; 24: 103–110.

Grundy

Stone

Bailey

, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. Epub ahead of print 3 November 2018. DOI: 10.1016/j.jacc.2018.11.002.

Sheridan

Viera

Krantz

, et al. Cardiovascular Health Intervention Research and Translation Network Work Group on Global Coronary Heart Disease Risk. The effect of giving global coronary risk information to adults: A systematic review. Arch Intern Med 2010; 170: 230–239.

Vlachopoulos

Xaplanteris

Aboyans

, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper of the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for research into arterial structure and physiology (ARTERY) Society. Atherosclerosis 2015; 241: 507–532.

10.

Hall

LML

Jung

Leese

. Controlled trial of effect of documented cardiovascular disease risk score on prescribing. BMJ 2003; 326: 251–251.

11.

Sheridan

Behrend

, et al. Individuals’ response to global CHD risk: A focus group study. Patient Educ Couns 2009; 76: 233–239.

12.

Grover

Lowensteyn

Joseph

, et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: The CHECK-UP Study: A randomized controlled trial. Arch Intern Med 2007; 167: 2296–2303.

13.

Grover

Lowensteyn

Joseph

, et al. Discussing coronary risk with patients to improve blood pressure treatment: Secondary results from the CHECK-UP Study. J Gen Intern Med 2009; 24: 33–39.